Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

CUSIP: 690469101

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
146,457,154
Total 13F shares
51,658,816
Share change
+2,539,546
Total reported value
$166,339,097
Price per share
$3.22
Number of holders
77
Value change
+$8,163,314
Number of buys
38
Number of sells
20

Security key

690469101

Report period

Q4 2023

Institutions

77

Top holders

10

Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BVF INC/IL
13F
Company
4.7%
6,851,051
$26,308,036 30 Sep 2023
13F
EcoR1 Capital, LLC
13F
Company
4.2%
6,117,400
$23,490,816 30 Sep 2023
13F
Rubric Capital Management LP
13F
Company
3.7%
5,445,910
$20,912,294 30 Sep 2023
13F
Madison Avenue Partners, LP
13F
Company
2.5%
3,648,509
$14,010,275 30 Sep 2023
13F
BlackRock Finance, Inc.
13F
Company
2.4%
3,520,344
$13,518,121 30 Sep 2023
13F
VANGUARD GROUP INC
13F
Company
2%
2,966,417
$11,391,042 30 Sep 2023
13F
Artal Group S.A.
13F
Company
1.7%
2,500,000
$9,600,000 30 Sep 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
1.2%
1,701,228
$6,531,000 30 Sep 2023
13F
JPMORGAN CHASE & CO
13F
Company
1.1%
1,613,409
$6,195,491 30 Sep 2023
13F
TLS Advisors LLC
13F
Company
0.9%
1,319,679
$5,068,000 30 Sep 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.82%
1,200,777
$4,611,542 30 Sep 2023
13F
STATE STREET CORP
13F
Company
0.76%
1,109,059
$4,258,787 30 Sep 2023
13F
CHI Advisors LLC
13F
Company
0.59%
864,822
$3,320,916 30 Sep 2023
13F
NORTHERN TRUST CORP
13F
Company
0.33%
478,810
$1,838,630 30 Sep 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.31%
458,700
$1,761,408 30 Sep 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.3%
444,966
$1,708,669 30 Sep 2023
13F
Bank of New York Mellon Corp
13F
Company
0.17%
250,080
$960,307 30 Sep 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.12%
170,036
$652,938 30 Sep 2023
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.1%
150,000
$576,000 30 Sep 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.1%
142,858
$548,576 30 Sep 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.08%
114,085
$438,086 30 Sep 2023
13F
Empowered Funds, LLC
13F
Company
0.07%
107,800
$413,952 30 Sep 2023
13F
FMR LLC
13F
Company
0.06%
91,506
$351,383 30 Sep 2023
13F
D. E. Shaw & Co., Inc.
13F
Company
0.06%
84,308
$323,743 30 Sep 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.06%
82,791
$317,909 30 Sep 2023
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.06%
81,173
$311,704 30 Sep 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.06%
80,800
$310,000 30 Sep 2023
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.04%
62,341
$239,389 30 Sep 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.04%
56,756
$217,943 30 Sep 2023
13F
UBS Group AG
13F
Company
0.03%
48,107
$184,731 30 Sep 2023
13F
BANK OF NOVA SCOTIA
13F
Company
0.03%
44,152
$169,544 30 Sep 2023
13F
MORGAN STANLEY
13F
Company
0.03%
43,117
$165,569 30 Sep 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
39,696
$152,433 30 Sep 2023
13F
Mirae Asset Global Investments Co., Ltd.
13F
Company
0.02%
32,231
$123,767 30 Sep 2023
13F
MetLife Investment Management, LLC
13F
Company
0.02%
31,717
$121,793 30 Sep 2023
13F
DCF Advisers, LLC
13F
Company
0.02%
30,430
$116,851 30 Sep 2023
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.02%
29,759
$114,275 30 Sep 2023
13F
SG Americas Securities, LLC
13F
Company
0.02%
26,064
$100,000 30 Sep 2023
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.02%
26,000
$99,840 30 Sep 2023
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.02%
25,825
$99,168 30 Sep 2023
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
24,850
$95,424 30 Sep 2023
13F
DEUTSCHE BANK AG\
13F
Company
0.02%
24,020
$92,237 30 Sep 2023
13F
Invesco Ltd.
13F
Company
0.02%
22,987
$88,271 30 Sep 2023
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.02%
22,077
$84,776 30 Sep 2023
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
19,110
$73,382 30 Sep 2023
13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM
13F
Company
0.01%
17,230
$66,163 30 Sep 2023
13F
Jump Financial, LLC
13F
Company
0.01%
15,811
$60,714 30 Sep 2023
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.01%
13,414
$52,000 30 Sep 2023
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
13,157
$50,523 30 Sep 2023
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
12,819
$49,000 30 Sep 2023
13F

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2023

As of 31 Dec 2023, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,658,816 shares. The largest 10 holders included TAKEDA PHARMACEUTICAL CO LTD, BVF INC/IL, EcoR1 Capital, LLC, Rubric Capital Management LP, BlackRock Inc., Madison Avenue Partners, LP, VANGUARD GROUP INC, Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, and JPMORGAN CHASE & CO. This page lists 77 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
64
Q4 2023 holders
77
Holder diff
13
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .